Supply chain, logistics

Alcami launches supply chain security offering

05-Oct-2016 By Melissa Fassbender

Alcami has announced its first to market Protect Your Brand™ offering, which it said will support companies looking to implement a backup supply option.

Packaging and serialization tech companies enter into global agreement

26-Sep-2016 By Melissa Fassbender

Systech International has extended its strategic partnership with the serialization automation supplier ServicePoint as the company looks towards the Russian serialization market.

update

Almac: investment to ensure space, staff, larger US footprint

21-Sep-2016 By Melissa Fassbender

Yesterday, Almac Group announced a $5.2m investment in its US-based operations, which its global VP of operations said will support customers “across the drug development lifecycle.”

Almac Group announces $5.2m expansion

20-Sep-2016 By Melissa Fassbender

In conjunction with its 20th year of business in North America, Almac Group has announced a $5.2m investment at its Durham, North Carolina facilities.

PSI selects goBalto's site ID cloud-based software to speed up trials

15-Sep-2016 By Staff Reporter

PSI has selected goBalto’s cloud-based Select module management system to help manage a multi-country Phase II clinical trial.

Cryoport launching logistics study for bioanalytical and clinical trial materials

30-Aug-2016 By Melissa Fassbender

The study will evaluate how critical biomarkers and cell-therapy cancer vaccines are impacted by temperature and transport packaging at deep frozen temperatures.

Marken expands capabilities with new pharma license at Moscow depot

24-Aug-2016 By Melissa Fassbender

Marken’s Moscow-based depot has been granted a new pharmaceutical license from the Russian Federation, further extending the company’s capabilities in the area.

Serialization initiative makes progress towards uniform track and trace model

16-Aug-2016 By Melissa Fassbender

The initiative brought together competing vendors working “side by side,” focusing on a common goal of creating industry-wide standards.

World Courier expands as Moscow becomes 'increasing popular destination'

15-Aug-2016 By Melissa Fassbender

World Courier is set to open a new Moscow, Russia-based investigational drug depot in August – and it will be nearly six times larger than the current depot.

Marken opens new GDP-compliant facility

15-Aug-2016 By Melissa Fassbender

The recently expanded and relocated GDP-compliant facility will operate 24/7/365 and is located in Zurich, Switzerland.

Almac Group services support first commercial orphan drug products

08-Aug-2016 By Melissa Fassbender

Almac Group has announced that two of its clients have recently received approvals of their first orphan drug product.

Payment tech automates reimbursements to clinical trial sites

20-Jul-2016 By Melissa Fassbender

The end-to-end reimbursement tool from Medidata uses clinical trial data to calculate costs and make payments to investigative sites in real time, all in the cloud.

CDMO Vetter to invest $320m in US-based manufacturing facility

13-Jul-2016 By Melissa Fassbender

The new manufacturing facility is the first of its kind to be developed outside of the company’s headquarters in Germany.

Regulatory changes 'defining' serialization processes: key considerations and opportunities

11-Jul-2016 By Melissa Fassbender

With deadlines around the corner, companies are beginning to plan their serialization initiatives – a process defined by regulatory changes, says Antares Vision.

Sequence and Adents team to help pharmas follow track & trace rules

07-Jul-2016 By Staff Reporter

Compliance consultant Sequence Inc. has partnered with software firm Adents to develop a track & trace solution for pharmaceutical products.

DIA 2016

endpoint releases new global supply management tool

28-Jun-2016 By Melissa Fassbender

endpoint has introduced its new clinical supply management tool DRIVE, which enables interactive response technology (IRT) functionality for non-IRT and investigator-sponsored trials.

Serialisation regulations to impact all corners of pharma, says Recipharm

27-Jun-2016 By Dan Stanton

The pharma industry is underprepared for the upcoming global regulations says Recipharm, which has inked three new tech deals as part of its €40m serialisation effort.

Marken expands as clients seek to ‘find suitable patients’ in remote areas

23-Jun-2016 By Melissa Fassbender

Marken has announced it is expanding its offerings to remote areas of the world, as clinical trials become increasingly more complex.

Parexel expands supply and distribution services in North America

24-May-2016 By Melissa Fassbender

Parexel recently opened a new North American Coordination Hub and Distribution Center in Pennsylvania, which will provide customers with clinical trial supplies and logistics services.

Recipharm will serialize customers' drugs for free until US and EU rules come into force

24-May-2016 By Gareth Macdonald

Recipharm has announced it will serialize customers’ products for free until legislation comes into force in key markets.

Aesica bolsters serialization tech offering

19-May-2016 By Staff Reporter

Aesica Pharmaceuticals has adopted a flexible serialization system capable of helping customer meet track and trace requirements in China, Korea and other key markets.

Almac launches pod for GDP, temperature-controlled shipping

10-May-2016 By Melissa Fassbender

The contract development and manufacturing organization (CDMO) launched its new Almac Pod™ service solution to safeguard customer’s products.

Marken preps for increased shipment volumes, expands capacity

04-May-2016 By Melissa Fassbender

Marken has announced an expansion of its third party service providers and customs brokers network to prepare for a “significant’ increase in drug, vaccine, API, and ancillary shipment volumes.

Almac Group launches new serialization solution

26-Apr-2016 By Melissa Fassbender

Almac Group has expanded its serialization capabilities to include its US commercial packaging facility in Audubon, PA.

BARDA talks medical countermeasure manufacturing

25-Apr-2016 By Melissa Fassbender

This year at Interphex, BARDA will discuss various strategies and innovations to reduce drug shortages and improve medicines availability.

Famar set to step into North America by buying Quebec plant from Bayer

18-Apr-2016 By Dan Stanton

European CDMO Famar says it will continue making products on behalf of Bayer after acquiring a Canadian manufacturing facility from the firm.

Supply chain fraud continues to plague companies, poll says

05-Apr-2016 By Melissa Fassbender

For the third year in a row, about 30% of Deloitte poll respondents say their companies experienced supply chain fraud, waste, or abuse in the previous year.

SGS and DiscoverX to supply bioassays for biosimilar development

04-Apr-2016 By Dan Stanton

SGS has teamed with DiscoverX to offer bioassays for assessing the potency of prospective biosimilars of Roche’s Avastin and BMS’s Erbitux.

Zenith and SEA Vision partner to offer track-and-trace service

21-Mar-2016 By Dan Stanton

Zenith Technologies and SEA Vision have teamed up to offer drugmakers a service they say will bring “seamless compliance” to upcoming serialisation regulations.

CORRECTION

Valeant divesting non-core Synergetics CMO business

16-Mar-2016 By Dan Stanton

Valeant is offloading the contract manufacturing business of ophthalmology and neurosurgery medical devices firm Synergetics, acquired last October.

AAI/CML claims clinical material production time reductions of 65%

14-Mar-2016 By .

AAIPharma and Cambridge Major Labs (CML) under a merged entity have driven efficiencies in end-to-end drug manufacturing, the firm says, dramatically reducing material delivery time.

Swiss and Indian regulators trying to determine how fake Harvoni reached Israel

10-Mar-2016 By Gareth Macdonald

The Swiss importer that supplied fake Harvoni to Israel has named the Indian manufacturer from which it bought the drug and is cooperating with an investigation say regulators.

Rumour: PCI Pharma Services looking for $1bn buyout says Reuters

08-Mar-2016 By Staff Reporter

Drug packaging and clinical trial supply firm PCI Pharma Services is looking for a buyer according to Reuters.

Preclinical consolidation creating 'service desert,' says Swiss CRO Anapath

25-Feb-2016 By Dan Stanton

Anapath has seen a surge in histotechnology services from Europe pharma and rival CROs as consolidation in the preclinical sector has left a lack of capacity for such work.

Recipharm to invest €40m in serialization tech ahead of EU and US track and trace rules

10-Feb-2016 By Gareth Macdonald

Recipharm will invest €40 in serialization equipment to ensure it can comply with evolving track and trace regulations in the US, Europe and other markets.

Chemical distribution trade group opens door to manufacturers

08-Feb-2016 By Staff Reporter

A newly established trade group has invited chemical manufacturers to apply for membership and announced plans to look at API and pharma-related issues.

Mafia behind most EU pharma cargo theft: €30m worth of drugs stolen each year says expert

04-Feb-2016 By Gareth Macdonald

The Mafia is responsible for most pharmaceutical cargo thefts in Europe according to a researcher who says €30m ($33.5m) worth of drugs are stolen while in transit across the continent each year.

Made in China: Envirotainer teams with drug and API shipper Air China Cargo

03-Feb-2016 By Gareth Macdonald

Envirotainer has partnered with Air China Cargo in deal that will see local and international drug and API makers use its range of cold chain shipping containers.

Catalent bringing clinical supply services to Japanese facility

21-Jan-2016 By Dan Stanton

Catalent will expand its cGMP facility in Japan to bring secondary packaging and clinical supply services to the region.

Strategic partnership aligns MG America and COMAS

04-Jan-2016 By Melissa Fassbender

MG America, the US subsidiary of MG2 Bologna, Italy, is expanding its filling division through a recent strategic partnership with COMAS.

Reefer Gladness? DEA OKs Catalent to supply marijuana from Missouri plant

09-Dec-2015 By Dan Stanton

Catalent has registered a facility in Missouri with the US DEA to import cannabis extracts in dosage form for clinical trial studies.

Correction

Strategic CRO relationships no more effective than traditional models, Tufts

25-Nov-2015 By Dan Stanton

Inconsistent practices and a lack of trust are restricting sponsors from fully realising the potential of CRO strategic partnerships, according to Tufts' Director Kenneth Getz.

Megamerger Pfall-out? $160bn Pfizer-Allergan deal to hit CROs in short-term, analysts

24-Nov-2015 By Dan Stanton

The $160bn Pfizer-Allergan megamerger could lead to booking cancellations in the short-term say analysts, but CROs – especially Icon, Parexel and PPD - should ultimately benefit.

TF opens giant Singapore storage and supply hub

19-Nov-2015 By Fiona BARRY

Thermo Fisher has opened a 70,000 sq ft GMP clinical supply hub in Singapore.

Roche: Small molecule exit will lead to outsourcing opportunities

16-Nov-2015 By Dan Stanton

Roche’s exit from four small molecule manufacturing plants will provide opportunities for third-party manufacturers, the firm says.

Horizon Pharma says ‘captive pharmacy’ accuser is ‘anti-competitive’

13-Nov-2015 By Fiona BARRY

Horizon Pharma has hit back at allegations it was secretly working with a “captive pharmacy” to preferentially dispense its own drugs, claiming its accuser is trying to reduce competition with its own distribution service.

AmerisourceBergen to 'set the bar' for compounding quality as it closes PharMEDium deal

09-Nov-2015 By Dan Stanton

Legislation allowing compounders to register as outsourcing facilities was a key driver in the acquisition of PharMEDium, AmerisourceBergen says as it completes the $2.6bn deal.

Lonza take note: Alexion looking to bring more manufacturing in-house

03-Nov-2015 By Dan Stanton

Alexion says it is looking to bring more manufacturing capabilities in-house, despite its CMO partner Lonza recently setting up a dedicated suite at a site in New Hampshire.

Pfizer-Allergan megamerger report prompts speculation about fallout for CROs

29-Oct-2015 By Staff reporter

Reports Pfizer is considering buying Allergan to create a company worth $330bn have once again raised fears of disruption for contract research organisations (CRO), although there are reasons to think the deal would be less troublesome than earlier megamergers.